|?FW%S(Z67,/ZSB~2T(?B|W(;_+}GGJ>=V
SYSTEM PROCESSING...
|?FW%S(Z67,/ZSB~2T(?B|W(;_+}GGJ>=V
SYSTEM PROCESSING...
Posted: 2025-05-07 16:54:31 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-07 16:54:45 UTC
Verified By
Rollup News
Novo Nordisk has cut its forecasts after seeing increased take-up of replica obesity drugs in the US market.
Novo Nordisk's revised forecasts
Impact of replica obesity drugs on Novo Nordisk's market share
US market dynamics for obesity drugs
Competition from replica obesity drugs
Maintaining market share in the face of competition
Adapting to changing market dynamics in the US